Search results
Forget Bank of America; Buy This Magnificent Bank Stock Instead
Motley Fool via Yahoo Finance· 10 hours agoBut things are changing when it comes to the bottom line. In the last three months of 2023, SoFi...
Oracle Chairman Larry Ellison tags Nashville as company’s next world HQ
KXAN via Yahoo Finance· 21 hours agoOracle Corp. co-founder and Chairman Larry Ellison has indicated that Nashville, not Austin, will be...
Lars Wingefors on why Embracer is going away, and what happens next
gamesindustry.biz· 4 hours agoWhen Embracer CEO Lars Wingefors declared an end to the company's nine-month restructuring program...
The Property Franchise Group PLC (LON:TPFG) most popular amongst retail investors who own 49% of the...
Simply Wall St. via Yahoo Finance· 13 hours agoSome investors might be encouraged by this, since private equity are sometimes able to encourage...
Ibotta’s IPO opens sharply higher, hinting at warming public-market interest in tech shares
TechCrunch· 6 days agoIbotta began its path as a public company on Thursday by opening at $117 per share, a big increase...
NPR just keeps on sliding more and more to the left as it unfolds into a complete crap show
New York Post· 4 days agoMore proof can be found on NPR’s own website by searching through its audited financial statements....
Donald Trump is about to become $1.2 billion richer. Here's why.
CBS News· 1 day agoDonald Trump is about to see his fortune grow by $1.2 billion. The former U.S. president is set to...
Oil And Gas Mergers Hit Record Q1 Levels In 2024
Forbes· 14 hours agoBig energy analytics and advisory firm Enverus reports this week that oil and gas upstream mergers and acquisitions reached a new first quarter high over...
General Electric Company (NYSE:GE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 hours agoGeneral Electric Company (NYSE:GE) Q1 2024 Earnings Call Transcript April 23, 2024 General Electric...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 hours agoTryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with ...
